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DOI: 10.1039/c0lc00132eWe describe an automated, self-powered chip based on lateral flow immunoassay for rapid,
quantitative, and multiplex protein detection from pinpricks of whole blood. The device incorporates
on-chip purification of blood plasma by employing inertial forces to focus blood cells away from the
assay surface, where plasma proteins are captured and detected on antibody ‘‘barcode’’ arrays. Power is
supplied from the capillary action of a piece of adsorbent paper, and sequentially drives, over a 40
minute period, the four steps required to capture serum proteins and then develop a multiplex
immunoassay. An 11 protein panel is assayed from whole blood, with high sensitivity and high
reproducibility. This inexpensive, self-contained, and easy to operate chip provides a useful platform
for point-of-care diagnoses, particularly in resource-limited settings.Introduction
Blood contains the most complete version of the human pro-
teome, and so provides a rich and convenient source of infor-
mation for disease diagnostics.1–3 Conventional clinical blood
protein diagnostic measurements are quantitative, but also time-
consuming. They require multiple steps, a significant amount of
blood sample, and can be awkward to multiplex when assaying
large panels of protein biomarkers, although there is recent
progress in this area.4–6 By contrast, lateral flow point-of-care
(LF-POC) devices, which are widely used for rapid detection of
blood biomarkers from patients in developing world settings, are
inexpensive, self-contained, simple to operate, and usually
require only small blood samples. However, they are neither
quantitative nor multi-parameter.7 Herein we report on a tech-
nology we call the Lateral Flow Integrated Blood Barcode Chip
(LF-IBBC) that is designed to encapsulate many of the advan-
tages of both standard and POC protein diagnostics while also
providing highly multiplexed measurements. The LF-IBBC
represents a significant advance over our previously reported
blood protein assay chips4,8 in terms of design simplicity,
measurement accuracy and reproducibility, and ease of manu-
facture and use.
Fig. 1 shows a summary of several of the design and opera-
tional aspects of a LF-IBBC. The chip is comprised of a micro-
fluidic layer fabricated from a hydrophilic polymer (NOA-63)
that is bonded to a glass microscope slide. Prior to assembly, theaNanoSystems Biology Cancer Center, California Institute of Technology,
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This journal is ª The Royal Society of Chemistry 2010microscope slide is patterned with DNA barcodes4,9 (see
Methods); thereafter, the LF-IBBC is stable towards long-term
storage. For blood protein assays, the DNA barcodes are con-
verted into antibody barcodes using the DNA-encoded antibody
library technique (DEAL).10–13 About 30 min (or less) prior to
use, the fluidic chambers 1, 2, and 3 are filled with the appro-
priate reagents (see the labels on Fig. 1a). To operate the chip,
a few microlitres (ml) of whole blood, with an anticoagulant, are
added into chamber 4 (Fig. 1a), and a filter paper is inserted into
the outlet slot shown at right. The capillarity of the filter paper,
coupled with the hydrophilic nature of the fluidic channel
surfaces, sequentially draws the blood and other reagents
through the chip, with the blood drawn first, and the wash buffer
drawn last (see labels of Fig. 1a). Thus, each step of a standard
enzyme-linked immunosorbent assay (ELISA) is automatically
and sequentially executed (Fig. 1d). The blood and reagents pass
from the chambers through a narrow channel, before exiting into
a wider assay channel. This scheme results in inertial focusing of
the blood cells into a central stream within the assay channel
(Fig. 1b) so that the assay surface is exposed only to flowing
plasma. During the flow-through process, serum biomarker
proteins are selectively captured onto specific stripes within the
antibody barcodes (Fig. 1c). The blood protein levels are recor-
ded in about 10 minutes after pinprick sampling, and the entire
assay development process takes 40 minutes. A GenePix array
scanner is utilized to record the fluorescence levels from the
individual barcode stripes, and automated software routines
convert those levels into protein abundances. Each barcode
constitutes a complete copy of the panel of blood biomarker
proteins assayed, and multiple barcodes are measured and
averaged per pinprick assay.4Results and discussion
Plasma separation from whole blood
For POC lateral-flow devices, a single paper film can provide
a filter for at least partially separating cells from whole blood, itLab Chip
Fig. 1 LF-IBBC design and operation. (a) Photograph of a chip containing two independently operated LF-IBBCs. The four reservoirs at left hold the
indicated blood or reagents for completing a multiplexed ELISA assay. The higher resolution images below highlight design details. The channel
connecting the chambers contains a high-density of microfabricated posts to filter impurities. A serpentile channel between chamber 4 and the narrow
section provides for reagent mixing upstream of the assay region. Adsorbent paper inserted into a slot in the waste outlet sustains fluidic flow due to
capillary action. Inertial focusing spatially separates plasma from whole blood, keeping the assay surface clear of blood cells over the length of the
barcode assay channel. (b) Plot showing how the diameter of the focusing channel influences the width of the fluid centroid that contains the blood cells.
(c) Proteins are detected using a variant of standard ELISA assays in which a barcode pattern of DNA-labeled capture antibodies provides a spatial
address for each protein in the panel. The inset represents a fluorescent readout of a completed barcode assay. (d) Real-time colorimetric imaging of
a solution flowing through a section of the barcode assay channel. Chambers 4, 3, 2, and 1 were loaded with 10, 8, 8, and 10 ml of dye solutions,
respectively (see color code). The evolving colors illustrate the time scale for the filter paper to sequentially drain the channels and complete the assay.
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View Onlinecan provide capillarity for pulling the blood and assay reagents
through the platform, and it can provide the assay surface (i.e. an
antibody-coated region of the paper is colorized if a certain
biomarker is present in the blood). We borrow some of these
concepts here. First, a small paper pre-filter is inserted into the
base of the blood chamber (chamber #4), which serves to remove
80–90% of the cells from the blood. This pre-purification, along
with the filter posts patterned into the microfluidic channel in the
region near the inlet chambers, keeps the chip from clogging, but
is insufficient for a quantitative and sensitive protein assay.
Further purification is achieved by pulling the blood through
a 10–20 mm wide, 2 mm long narrow channel (Fig. 1a and S1,
ESI†), before it exits into the much wider (500 mm wide), 1.5 cm
long barcode assay channel. Inertial lift forces were employed to
axially focus the cells within the assay channel. Such forces have
been well-studied, and have multiple contributions that include
the wall-effect force and the shear-lift force.14–17 The wall-effect
force, for example, describes forces that are normal to a wall, and
are experienced by a particle that is flowing parallel to that wall.
This force thus pushes particles towards the center-line. The net
result is that the blood cells do not interfere with the protein
assays. Fig. 1b illustrates how the dimensions of the narrow
channel influence the column diameter of the focused blood cells.Lab ChipThe final design dimensions of the narrow channel (2 mm long,
12 mm wide) provided excellent focusing along the entire length
of the assay channel for both spherical cells and disk like
erythrocytes (Fig. 1b and S2, ESI†), thus keeping the assay
surface clear of blood cells. In general, the extent of focusing also
depends upon the flow rate (Videos 1–5,ESI†), although for the
current design this dependence is weak (Fig. S2, ESI†). This
design thus permits a seamless integration of a plasma separation
function with a lateral-flow immunoassay, all within the same
microfluidic channel, and without skimming, and so takes
advantage of a larger fraction of the plasma than a Zweifach–
Fung design.18–20Powering fluidic flow
The high-wettability filter paper inserted at the waste outlet of
the chip draws flow for >2 h. Reliable fluid flow also requires
hydrophilic microchannel surfaces. Although the commonly
used microfluidic elastomer, polymethylmethacrylate (PMMA),
can be made hydrophilic by O2 plasma treatment, use of the
naturally hydrophilic polymer NOA 63 yielded a more stable and
robust solution. We calibrated the filter-paper driven flow
through an LF-IBBC using a mass-flow controlled syringe-pumpThis journal is ª The Royal Society of Chemistry 2010
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View Onlinepowered chip. Using measurements of the trajectory of flowing
cells (driven by the two different power sources) we were able to
estimate that the filter paper pulls solutions at a velocity of 0.67–
1.34 mm s1 (0.5–1 ml min1) through the barcode assay channel
(Videos S2, S3 and S5, ESI†). Reagent chambers are drained
sequentially, so that the blood in chamber #4 is depleted first,
followed by chambers 3, 2, and 1. The dense posts between the
reagent chambers are designed to filter impurities as well as
increase flow resistance. This potentially retards mixing of fluids
in one chamber with those from the neighboring chambers
during stepwise depletion. In addition, the capillarity in each
chamber can also contribute to the stepwise depletion since
typically as the fluid within a chamber is drained, the relative
meniscus height increases. We recorded the stepwise depletion
effect by loading different dyes into the four chambers, and then
imaging the fluid, over time, at a fixed point in the barcode assay
channel (Fig. 1d and Video S6, ESI†). Each color dominated the
image for about 10 min. Thus, each of the steps constituting
a standard ELISA assay, from sample introduction to secondary
antibody binding, fluorophore binding, and washing, are
executed without human intervention (Fig. S4b, ESI†).Multiplex protein barcode assay
The microfluidic-based flow patterning technique generates
DNA barcode-type arrays, comprised of 20 mm wide stripes at
a 50 mm pitch, that are 10 higher density than standard, spotted
microarrays.4 The barcodes are patterned over the majority of
the glass slide surface, which alleviates the need for alignment of
the LF-IBBC assay channel with the barcodes during chip
assembly. The DNA barcodes are stable against both the
subsequent microfluidics fabrication steps and long term chip
storage. They are converted into antibody barcodes by flowing
through a cocktail of DNA-labeled antibodies against the
proteins within the biomarker panel. Each antibody is labeled
with 3 copies of a ssDNA oligomer that is complementary to
one of the ssDNA barcode stripes, but orthogonal to all other
stripes. Sequences of the DNA oligomers used here are given in
Table S1, ESI†, and the antibody pairs used are presented in
Table S2, ESI†.
The DNA flow patterning procedure generates DNA barcode
stripes of very high aspect ratio: 20 mm width and 0.5 m long.
We optimized the flow-patterning technique to emphasize high
and uniform DNA loading over the entire length of the stripes
(see Methods). We previously demonstrated that these improved
barcodes could be utilized to assay a panel of cytoplasmic
proteins from a single lysed cancer cell.9 Here we demonstrate the
use of those barcodes for detecting a panel of blood proteins
using the LF-IBBC. We assayed freshly collected pinpricks of
blood for a panel of 11 proteins. These proteins were C-terminal
reactive protein (CRP), matrix metalloproteinase 3 (MMP3),
serine proteinase inhibitor (Serpin), granulocyte colony-
stimulating factor (GCSF), macrophage migration inhibitor
factor (MIF), epidermal growth factor (EGF), chemokine (C–C
motif) ligand 5 (CCL5), vascular endothelial growth factor
(VEGF), interleukin 8 (IL-8), IL-1b, and interferon-g-induced
protein (IP 10). These proteins are variously associated with
tumor progression, inflammation, and other disease condi-
tions.21–24 Stripe 12 was functionalized with mouse IgG1 isotypeThis journal is ª The Royal Society of Chemistry 2010control to measure the level of non-specific binding for the assay.
Quantitation and assay cross-reactivity data for this panel are
provided in Fig. S5, ESI†.
In Fig. 2 we present data collected from assaying the biomarker
panel from a pinprick of whole blood on a LF-IBBC. A contact-
activated lancet was employed to prick a finger of a healthy donor.
Immediately thereafter, a capillary blood collection tube prefilled
with 1 ml of 150 mM citrate anticoagulant solution was used to
collect 10 ml blood, which was then transferred to chamber #4 of
3 separate LF-IBBC (for triplicate measurements to test the
reproducibility of the barcode assays) with chambers 1–3 already
pre-filled with their designated reagents. Filter paper was inserted
at the end of the device, and after 40 minutes the assay was
complete. The microfluidic layer was peeled off the glass slide, and
the barcode fluorescence intensities were scanned and digitized
using a GenePix array scanner and custom written software. In
Fig. 2a we present eight barcode assays, both in image and digi-
tized form, from one of these chips. These assays, along with the
statistical analysis of Fig. 2b, illustrate how highly uniform bar-
coding chemistry translates into highly reproducible protein
assays. Four of the proteins in the panel, including VEGF
(detection limit 60 pg ml1 (1.3 pM)) and IL-8 (detection limit
20 pg ml1 (2.5 pM)), were below the detection threshold, which
is not surprising for a healthy donor. The detection limits for the
LF-IBBC assays are only slightly higher than the manufacturer
specifications for the individual ELISA assays (15 pg ml1 for
IL8 and 30 pg ml1 for VEGF).
At sufficiently high flow velocity, the time to complete a flow-
through assay is limited by the kinetics of antibody/analyte
binding,25 rather than by diffusion (as in a standard 96-well plate
format). The flow velocity of blood through the LF-IBBC barcode
assay channel is1 mm s1, which implies that the LF-IBBC assay
should be nearly kinetically limited, with each assay step requiring
5 to 10 minutes. By varying the amount of fluids loaded in
chambers 1–4, we varied the assay time (Fig. 3) and found that the
amount of protein detected slightly increases between the 20 and
40 minute assays (corresponding to 5 and 10 min per step).
Conclusion
The Lateral-flow Integrated Blood Barcode Chip draws from
advantages presented by standard, quantitative blood immuno-
assay procedures and point-of-care lateral flow immunoassays.
Whole blood is readily handled on-chip via a hydrodynamic
focusing scheme that spatially separates cells and plasma within
the same fluidic channel. Adsorbent filter paper provides power
to drive all the steps of a quantitative, highly multiplexed ELISA-
like immunoassay. In addition, a reproducible patterning tech-
nology for preparing antibody barcodes integrated into the
microfluidic assay channels provides for both a high level of
sensitivity and quantitation for rapidly assessing the levels of
a panel of blood proteins.
Materials and methods
Microchip fabrication
General procedures for microchip fabrication using poly-
dimethylsiloxane (PDMS) were described previously.26 A high-
resolution chrome mask was used for photolithography; its
features were replicated on a 4 inch silicon wafer with negativeLab Chip
Fig. 2 Multiplex LF-IBBC protein assay from whole blood. (a) A representative fluorescence image of 8 barcodes each recording an identical panel of
11 proteins. Each barcode is bounded by a green fluorescent alignment marker. Each red bar records a unique protein; protein locations are determined
relative to the alignment markers. The integrated fluorescence intensity of the 8 barcodes is presented below the fluorescent image, and reflects how
reproducible barcode patterning leads to reproducible protein assays. (b) Fluorescence intensity of the first 5 biomarkers at each barcode repeat. (c)
Correlation of the fluorescence intensity and corresponding protein concentrations for IL-8 and VEGF in logarithmic scale. The data reflect a better
than 10% measurement error, except for the proteins present at the lower detection limits (<20 pg ml1). Eight whole barcodes were used to generate the
mean fluorescence intensities and measurement uncertainties. The dashed lines are power law fits to guide the eyes.
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View Onlinephotoresist (SU-8 2025, Microchem), yielding a master for
molding PDMS (Methods, ESI†). Masters for fabricating NOA
63 (Norland) devices required further treatment: a layer of
aminosilane was grafted on the surface of the master mold by O2
plasma activation at 25 W for 30 s, followed by immersion in 2%
3-(aminopropyltriethoxysilane) (APTES, Sigma-Aldrich) in
acetone for 10 min. The master was washed sequentially with
isopropanol and DI water before an N2 blow dry. A thin layer of
monoglycidyl ether-terminated PDMS (Sigma-Aldrich) was
spun with a speed of 1000 rpm for 30 s on the modified master,
and subsequently incubated at 80 C for 4 h. The master was then
cleaned with isopropanol and dried under streaming N2. The
resulting PDMS monolayer on the master prevented NOA 63
from sticking to the surface.27 To make a NOA replica, an
aluminium plate with cutouts was fitted over the silicon master
such that the SU-8 features were exposed through the cutouts.
NOA 63 was poured into the cutouts, and the assembly was
treated for 5 minutes with UV exposure before the NOA replica
was peeled off. The replica was further processed by drilling
chamber holes with a standard drill press and trimmed to
appropriate dimensions. Finally, UV treatment was performed
again to render the surface permanently hydrophilic before
bonding to a DNA-patterned barcode array slide.27,28
Barcode array patterning
The high-density DNA microarray was patterned using
a microfluidic device also fabricated by soft-lithography (Fig. S3,Lab ChipESI†). In order to generate highly consistent barcode arrays,
a silicon hard master was generated by transferring photolitho-
graphically defined patterns into an underlying silicon wafer
using deep reactive ion etching (DRIE). Following standard soft-
lithography procedures, a pre-cure PDMS mixture was poured
onto the hard master and heated at 80 C for 40 min. The PDMS
replica was cutout, access holes to the channels were punched,
and the device was bonded to a polylysine glass slide (Erie
Scientific Company) at 80 C for 1 hour. The barcode device
consists of 20 microchannels, each 20 mm wide and spaced at a 30
mm interval, winding across a 1.500  100 area. Thirteen of those
channels were individually filled with unique 30–33mer oligo-
nucleotides A–M (sequences in Table S1, ESI†), each at
a concentration of 266 mM in 33% DMSO; a simple 3 psi pressure
gradient was used to drive flow. The DNA solutions were
allowed to evaporate in a desiccator, after which the PDMS
device was removed and the glass substrate was baked at 80 C
for 4 h. Finally, the substrate was thoroughly washed with DI
water to yield a barcode array slide that could be stored under
desiccation for months.Collecting finger-prick blood
The collection procedure complies with the protocol approved by
the Institutional Review Board of the California Institute of
Technology. A microtainer contact-activated lancet (BD
Science) was used to obtain 10 ml of blood from a healthyThis journal is ª The Royal Society of Chemistry 2010
Fig. 3 Statistical comparison of 20 min and 40 min multiplexed protein
assays using a LF-IBBC and pinpricks of whole blood from a single
healthy donor. Mean fluorescence intensities are presented for each
biomarker. Each measurement was performed in triplicate using 3
separate LF-IBBCs, but the same pinprick sample from a healthy donor.
For each individual LF-IBBC assay, 8 barcodes were averaged to yield
the measured protein levels. For this bar graph, the 3 separate LF-IBBC
assays were then averaged. The error bars represent the measured stan-
dard deviation across the three separate LF-IBBC measurements.
Differences between the 20 and 40 min LF-IBBC assays are calculated
using the two-tailed Student’s t-test: (*), (**) and (***) indicate signifi-
cant differences at P < 0.05, 0.01 and 0.001, respectively. The 40 min
assay is clearly the most sensitive, but increasing assay times an addi-
tional 25–30% did not further increase sensitivity.
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View Onlinedonor. The whole blood was collected with SAFE-T-FILL
capillary blood collection tubes (RAM Scientific) which are
prefilled with 1 ml of 150 mM citrate solution as an anti-coagu-
lant, and then immediately transferred to the one-step chip for
analysis. Any surface contaminated by blood was disposed of
according to standard biohazard disposal protocols.Blood cell self-focusing observation
The narrow focusing section was fabricated at various lateral
dimensions while maintaining an identical 31 mm height. A
syringe pump was used to generate steady flow rates for blood
through the microchannels, and visual comparison of blood cell
flow powered by filter paper and syringe pumps led to estimated
flow rates in the barcode readout channel. Cell focusing profiles
were generated by superimposing 50 consecutive images taken at
the middle of the barcode readout channel with exposure time
0.187 s, and subsequently inverting the white/black color.Microchip operation and observation
The capture antibody array was created using the DEAL tech-
nique (Fig. S4 and Methods, ESI†). Prior to loading any solu-
tions, a piece of asymmetric polysulfone membrane (PALL) was
placed at the bottom of the blood chamber 4 (Fig. 1). A piece of
filter paper (grade 50, Whatman) was placed at the end of the
microchannel. The blocking step was performed by adding 20 ml
3% w/v bovine serum album (BSA, Sigma-Aldrich) in phosphate
buffer saline (PBS) to chamber 4. Induced by capillary flow, the
BSA solution spontaneously filled up all channels within 5 min.This journal is ª The Royal Society of Chemistry 2010After 20 min, the chambers were drained by pipetting to remove
residual solutions. Chamber 4 was refilled with 10 ml of a cocktail
containing 11 DNA-labeled antibodies (Table S2, ESI†), at
a concentration of 25 mg ml1. Chamber 3 was filled with 10 ml 3%
BSA (Fig. S4a, ESI†). The microchip was ready to run when all
the chambers were depleted of solutions. Alternatively, the chip
may be sealed and stored in a refrigerator at 4 C after removal of
the filter paper. No obvious alteration of the DEAL antibody
array quality was observed after one month of storage (data not
shown).
To perform a 40 min assay, 7 ml of whole blood sample, 5 ml
detection antibodies (Det Abs) at 25 mg ml1, 5 ml streptavidin–
cy5 at 10 mg ml1 and 15 ml 3% BSA w/v in PBS were loaded into
chambers 4, 3, 2, and 1, respectively (Fig. S4b, ESI†). To test
assay sensitivity, a 7 ml aliquot of a solution of recombinant
proteins at designated concentrations in 1% BSA/PBS solution
replaced the blood sample. 20 min assays were conducted by
halving the amount of reagents in each chamber. All assays were
conducted at room temperature, although ongoing study found
that sensitivity tended to be higher as environmental temperature
rose.Data analysis and statistics
The LF-IBBC can be read directly under a fluorescence micro-
scope. However, we adopted a GenePix 2000B (Axon Instru-
ments) array scanner for data acquisition, since it is designed for
similar purposes for spotted arrays. Before GenePix analysis, the
glass substrate was separated from the elastomer chip and
immediately dipped 3 times in freshly prepared PBS solution
with 0.05% Tween 20, followed by 2 dips in DI water and air
drying. The GenePix scanner contains dual lasers with appro-
priate optical filters to detect Cy3 at 532 nm and Cy5 at 635 nm.
The parameters for the scanner were set as follows: laser power
80% and gain 600 for Cy5, laser power 15% and gain 450 for Cy3.
The fluorescence signal profile was processed by ImageJ (NIH)
and a custom-written Excel macro. The fluorescence intensity of
barcodes in each device was extracted and averaged. The stan-
dard deviations of those barcodes represent error bars, which
indicate self-consistency of assay. To assess the effect of assay
time, the mean fluorescence intensity of barcodes from each
assay time (triple repeats) was obtained and Student’s t-test was
applied to calculate P-value at a significance level of at least 0.05.Acknowledgements
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